Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2012        Go!    
 
 
June 26, Monday 2017 10:45 AM       

       HEADLINES: Handwriting is not that of Pulsar Suni’s, Dilip’s statement to be recorded                                              Woman tied to tree and assaulted, an insult to state, says Chennithala                                              Telephonic conversation between Dilip’s manager and Vishnu exposed                                              Unexpected hurricane at Kundamkulam                                              K R Mohanan dies                                              Five more TN fishermen arrested by Sri Lankan Navy                                              Modi greets nation on Eid, says diversity is India's strength                                              123 killed, 100 injured as oil tanker explodes in Pak                                              Malaysia-bound AirAsia flight ‘shaking like washing machine’ returns to Aus                                              Shiv Kapur makes cut, but slips to T-42nd in Germany                                              Super Srikanth lifts Australian Open Super Series                                              BAI announces Rs 5 lakh for Srikanth                                              Kaumudi Facebook
       SCI&TECH Next Article: Mysterious 'Higgs Bison' species identified  
       Male birth control shots may lower pregnancy odds: study
 
         Posted on :19:04:16 Oct 28, 2016
   
A A
       Last edited on:19:04:16 Oct 28, 2016
         Tags: Male birth control, lower pregnancy odds, stu
 
GENEVA: An experimental birth control vaccine for men can effectively prevent pregnancy in their female partners by lowering sperm count, scientists including those from India have found. Researchers are working to perfect the combination of hormonal contraceptives to reduce the risk of mild to moderate side effects, including depression and other mood disorders.
 
"The study found it is possible to have a hormonal contraceptive for men that reduces the risk of unplanned pregnancies in the partners of men who use it," said Mario Philip Reyes Festin, from the World Health Organisation (WHO) in Switzerland. "Our findings confirmed the efficacy of this contraceptive method previously seen in small studies," said Festin.
 
Researchers, including Man Mohan Misro of the National Institute of Health and Family Welfare in New Delhi, tested the safety and effectiveness of injectable contraceptives in 320 healthy men ages 18 to 45.
 
The participants had all been in monogamous relationships with female partners between the ages of 18 and 38 for at least a year. The men underwent testing to ensure they had a normal sperm count at the start of the study.
 
The men received injections of 200 milligrams of a long-acting progestogen called norethisterone enanthate (NET-EN) and 1,000 milligrams of a long-acting androgen called testosterone undecanoate (TU) for up to 26 weeks to suppress their sperm counts.
 
Healthcare professionals gave the men two injections every eight weeks. Participants initially provided semen samples after eight and 12 weeks in the suppression phase and then every 2 weeks until they met the criteria for the next phase.
 
During this time, the couples were instructed to use other non-hormonal birth control methods. Once a participant's sperm count was lowered to less than one million/ml in two consecutive tests, the couple was asked to rely on the injections for birth control.
 
During this period known as the efficacy phase of the study, the men continued to receive injections every eight weeks for up to 56 weeks. Participants provided semen samples every eight weeks to ensure their sperm counts stayed low. Once the participants stopped receiving the injections, they were monitored to see how quickly their sperm counts recovered.
 
The hormones were effective in reducing the sperm count to one million/ml or less within 24 weeks in 274 of the participants. The contraceptive method was effective in nearly 96 per cent of continuing users. Only four pregnancies occurred among the men's partners during the efficacy phase of the study.
 
Researchers stopped enrolling new participants in the study in 2011 due to the rate of adverse events, particularly depression and other mood disorders, reported by the participants. The men reported side effects including injection site pain, muscle pain, increased libido and acne. The study was published in the Journal of Clinical Endocrinology and Metabolism.
A A
       SCI&TECH
Next Article: Mysterious 'Higgs Bison' species identified
 
 
SCI&TECH HEADLINES
Theweightmonitor.com launches mobile app for easier access to one-stop weight management platform  
New drug to treat blood cancer developed  
Threat of asteroid impact looming over Earth: experts  
Hottest known planet in universe discovered  
Wireless, battery-less pacemaker developed  
'Manned missions to Moon, Mars may face medical emergencies'  
Ransomware threat: Centre activates mechanism to prevent ‘Wannacry’ cyber attack  
2 lakh hit by 'unprecedented' cyberhack in 150 nations:Europol  
foodpanda revamps mobile app; provides more options  
ixigo launches trains app for Apple iOS users  
Virtual humans may help doctors learn empathy: study  
Gamers, here are five games to watch out for  
Yahoo India homepage gets brand new look  
Spacecraft flies between Saturn and rings in historic 1st  
Google targets 'fake news,' offensive search suggestions  
Offensive WhatsApp posts can land group admin in jail  
Facebook for 'everyone' and not just high end: Zuckerberg  
Google Earth re-invented for new era  
NASA images show how India looks from space at night  
Signs of life detected below world's deepest point  
'iPhones assembly in Bengaluru by Apple in less than a month'  
Five astronauts assigned to future ISS mission: NASA  
Trump plans to send humans to Mars  
First patient cured of rare blood disorder'  
Indian-American teen wins top science award worth USD 250,000  
 
Actress case: Do you think Pulsar Suni's letter is part of a conspiracy?
yes
 
no
 
don't know
 
 
 
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]kaumudi.com
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy